IFP Advisors’s Sagimet Biosciences SGMT Stock Holding History

IFP Advisors’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$3.26K	–	5008
2025 Q1	$3.26K	Buy	+1,000	New	+$4.2K	﹤0.01%	2987

Other funds holding SGMT

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

IFP Advisors's SGMT Position: Q2 2025 in Review

IFP Advisors sold out of Sagimet Biosciences (SGMT) in Q2 2025, closing a stake of 1,000 shares — an estimated $3.26K sold.

IFP Advisors first reported a position in SGMT in Q1 2025 and held it in 1 quarter. The position peaked at $3.26K in Q1 2025. 67 funds tracked by Wall St. Rank hold SGMT as of Q2 2025.

IFP Advisors reported no remaining Sagimet Biosciences position as of Q2 2025 after selling out during the quarter.
IFP Advisors sold 1,000 Sagimet Biosciences shares in Q2 2025, an estimated $3.26K.
IFP Advisors first reported a position in Sagimet Biosciences in Q1 2025 and held it in 1 quarter.
IFP Advisors's Sagimet Biosciences position peaked at $3.26K in Q1 2025.
67 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.